Randomised controlled trial of high‐flow nasal cannula in preterm infants after extubation
نویسندگان
چکیده
HFNC therapy is increasingly used as ‘non-invasive’ respiratory support for preterm infants. A 2016 Cochrane Review found that had similar efficacy to NCPAP infants following extubation,1 but further studies were needed, particularly in extremely born <28 weeks' gestation, who are at highest risk of extubation failure. The trial by Uchiyama et al the largest randomised post-extubation infants, and one only a few enrol (168 enrolled; 76 HFNC, 92 NCPAP/NIPPV). This multicentre non-inferiority NCPAP/NIPPV was superior (and did not satisfy criteria) primary outcome treatment failure within 7 days. Reintubation rates similar; more than 80% met criteria avoided reintubation due crossover NCPAP/NIPPV. Like previous trials2-4 intervention blinded, although objective used. In group, 149 received 47 NIPPV extubation. both groups, escalation clinician discretion. As control group could receive either or NIPPV, definition ‘treatment failure’ blurred: some before others not. It reported whether inflations synchronised with infant's breathing not, which may be important.5 design reasonable given existing evidence, sample size calculation assumed rate 9% higher NCPAP/NIPPV, chosen margin rather large. There an imbalance allocation (47%) (53%). total 378 ultimately recruited study (38 required, even inflation anticipated dropouts); however this represents 33% eligible has implications generalisability results. use stimulants prior reported. prospectively registered; however, there inconsistencies between registration published stated size, comparator outcome. starting gas flow >2 L/min, lower studies,3, 4 it unclear maximal permitted 8 L/min being determined. increasing associated increased delivered pressure,6 have contributed decreased group. Extubation important concern neonatal clinicians, optimal mode remains uncertain. results tip balance favour initial support; consistent when ‘backup’ For most immature failure, seems prudent avoid using support. authors no conflicts interest declare. https://ebneo.org/HFNC-after-extubation
منابع مشابه
High-flow Nasal Cannulae in Very Preterm Infants after Extubation
BACKGROUND The use of high-flow nasal cannulae is an increasingly popular alternative to nasal continuous positive airway pressure (CPAP) for noninvasive respiratory support of very preterm infants (gestational age, <32 weeks) after extubation. However, data on the efficacy or safety of such cannulae in this population are lacking. METHODS In this multicenter, randomized, noninferiority trial...
متن کاملWeaning preterm infants: a randomised controlled trial.
OBJECTIVE To assess the effect on growth and iron status in preterm infants of a specially devised weaning strategy compared with current best practices in infant feeding. The preterm weaning strategy recommended the early onset of weaning and the use of foods with a higher energy and protein content than standard milk formula, and foods that are rich sources of iron and zinc. SUBJECTS AND DE...
متن کاملHigh dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.
OBJECTIVE To compare two dosing regimens for caffeine citrate in the periextubation period for neonates born at less than 30 weeks gestation in terms of successful extubation and adverse effects. DESIGN A multicentre, randomised, double blind, clinical trial. SETTING Four tertiary neonatal units within Australia. PATIENTS Infants born less than 30 weeks gestation ventilated for more than ...
متن کاملRandomised controlled trial of colloid infusions in hypotensive preterm infants.
Colloid infusions are often given to treat hypotension in preterm infants. The aim of this work was to assess whether it was the amount of protein or the volume of the colloid infused which accounted for the observed increase in blood pressure. Sixty preterm infants were randomised (20 in each group) to receive 5 ml/kg 20% albumin, 15 ml/kg fresh frozen plasma, or 15 ml/kg 4.5% albumin. All inf...
متن کاملRandomised controlled trial of cisapride in preterm infants.
AIM To determine the effect of cisapride on gastrointestinal motility in preterm infants. METHODS Cisapride (0.2 mg/kg, 8 hourly ) or placebo was given first for seven days in a double blind randomised crossover study of 10 preterm infants. Gastrointestinal motility was assessed on day 3 of each treatment. The half gastric emptying time (GET1/2) was determined by using ultrasonography to meas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Paediatrica
سال: 2021
ISSN: ['0803-5253', '1651-2227']
DOI: https://doi.org/10.1111/apa.15848